Rapid urbanization and a growing number of nuclear families have led to increased pet ownership, which has directly resulted in the expansion of the veterinary diagnostics market. Pet owners take no chances, and are quick to avail diagnosis and situational check-ups at the slightest inclination of health anomalies. Companion animals and livestock are healthier and live longer since their owners are willing to spend more on veterinary care and supplements. Recently, technological advancements have made it possible for veterinarians to expedite their duties with greater precision, so that they can diagnose diseases, monitor responses to therapies, and look for the presence of underlying diseases in apparently healthy animals.

Adoption of speedier and more accurate diagnostic techniques 

In recent times, technological advancements in the global veterinary diagnostics market have been aimed at developing speedier techniques, using which a definitive answer can be provided within 24 hours, if not during the initial examination of the animal. These methods must fulfil the prerequisites of swiftness, sensitivity, specificity, and cost-effectiveness. Conventional immunoassays such as dot immunoperoxidase test, used for the identification of Bluetongue virus, and improved immunoassays like ELISA, used for the Foot and Mouth Diseases (FMD) virus, fulfil the prerequisites of sensitivity and specificity. Pen-side diagnostic tests like immunochromatographic assays, based on lateral flow principle for the diagnosis of rabies, fulfil the criteria of swiftness.

Introduction of biotechnological assays

Another major technological breakthrough in the global veterinary diagnostics market is the introduction of biotechnological assays. These new biotechnologies use expression vectors, recombination, and synthetic peptides to produce more specific peptides. Traditional variants of diagnostic assays have been made more specific and sensitive with the help of monoclonal antibodies.

More efficient and accurate technologies, such as genetic engineering on farm animals, nuclear transfer for cloning animals, and gene therapy for the treatment of diseases in pets have reduced the time taken and costs of diagnosis associated with conventional technologies. Biochip-based technology, along with biosensors are cementing their place in the veterinary diagnostics market, while molecular diagnosis and polymerase chain reaction are also gaining prominence. 

The future of molecular biology in the field of veterinary diagnostics looks bright. The introduction and increasing adoption of transgenic technologies have already produced transgenic animals such as mice, rats, rabbits, pigs, sheep, and cows. Transgenic technologies help improve the productivity of farm animals. For example, transgenic cattle produce milk which contains particular proteins that help treat human emphysema. These developments have accelerated the demand for veterinary diagnostics globally.